十大正规买球平台-网上靠谱正规买球网站

十大正规买球平台-网上靠谱正规买球网站

CN

cooperation

Established close industry-university-research cooperation relationship with Shanghai University and Suzhou Institute of Biomedical Engineering Technology, Chinese Academy of Sciences

01
Cooperation with Shanghai University

With the help of the school's professional advantages in automatic control and software engineering,

Focus on the research and development of high-end molecular diagnostic instruments such as automatic nucleic acid extraction and purification instrument, magnetic particle chemiluminescence immunoassay instrument, etc.

More
02
Chinese Academy of Sciences
Suzhou Institute of Biomedical Engineering Technology

In cooperation with the Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, the focus is on the development of rapid nucleic acid detection instruments for the new coronavirus.

More

products

  • 临床检验器械
  • 诊断试剂盒
  • 样本采集及处理
  • 关键原材料
  • 分子POCT核酸快检

    应用场景:如用于新型冠状病毒的核酸快速检测。


    More
    磁微粒-吖啶酯化学发光仪

    主要用于重症感染多标志物联合检测

    More
    全自动核酸提取纯化仪NEM-24

    工作原理:磁珠吸附法

    结构组成:由机械部分和电气部分组成

    More
    全自动化学发光免疫分析仪 Mac-S
    (磁微粒、吖啶酯、直接发光)

    定位:高效、快速、小型、低通量、多指标

    可在病人床边应用的POCT产品。

    More

    development

    2021

    The Anhui Provincial Department of Human Resources and Social Security approved the establishment of a provincial post-doctoral research station.
    Immuno-POCT production line-automatic chemiluminescence immunoassay analyzer was approved for marketing.
    Immune POCT production line - IL6, IL10, PCT, SAA, passed the registration test.
    The immune POCT production line-influenza virus immunochromatographic rapid detection kit was successfully developed.
    Molecular POCT production line-New coronavirus nucleic acid RPA rapid detection kit was successfully developed.
    The cell capture platform-cell sorter and CTC identification reagent were successfully developed.
    Medical rehabilitation platform-electronic moxibustion therapeutic apparatus, completed multi-center clinical trials and submitted to Anhui Provincial Food and Drug Administration for registration review.
    The science and technology projects in Anhui Province and Xuancheng City have passed the acceptance.

    2020

    high-tech enterprises
    Xuancheng Molecular Diagnostics High-end Medical Device Engineering Technology Research Center
    The revenue exceeds 20 million yuan, and it is included in the "industrial enterprises above designated size"
    Xuancheng's "Top Ten" Science and Technology Innovation Enterprises
    Immune POCT production line - fully automatic chemiluminescence immunoassay analyzer, passed the registration inspection.
    Immune POCT line-infection detection markers into production transformation.
    Core raw materials: Nano magnetic beads and colored microspheres were successfully developed and put into application
    Received the Announcement City 2020 Science and Technology Project.
    6 new patents have been applied, including 3 invention patents.

    2019

    The project was approved by the high-level scientific and technological talent team of Anhui Province
    Won the key research and development project of Anhui Provincial Department of Science and Technology
    Announced city science and technology project project
    Immuno-POCT production line-automatic chemiluminescence instrument was successfully developed
    Diagnostic reagent GMP workshop was constructed and put into production
    Exosome purification reagent successfully developed
    3 new patent applications

    2018

    Fully automatic nucleic acid extraction and purification instrument was approved for listing; won the "Zhong Nanshan Science and Technology Innovation Award"
    The first prototype of the fully automatic chemiluminescence instrument was successfully developed and entered into the functional test

    2017

    2017.9.29The company was established
    Complete plant construction within 2 months

    • 2021
    • 2020
    • 2019
    • 2018
    • 2017

    news

  • 2022-02-12 安徽十大平台网赌姜剑国先生荣获宣城“特殊人才”奖

    虎年新春,为真生物旗下子公司安徽十大平台网赌传喜讯。在2月9日国家级宣城经济技术开发区召开的“双招双引项目建设暨工业发展大会”上,安徽

  • 2022-01-19 医学魔改大师玩跨界,CRISPR遇见分子诊断

    2020年,瑞典皇家科学院将诺贝尔化学奖授予Jennifer Doudna教授Emmanuelle Charpentier博士以表彰她们在CRISPR/Cas9基因编辑方法上

  • 2021-09-13 为真生物与桐树基因签署十年战略合作,共创伴随诊断产品市场新概念

    为真生物与桐树基因签署十年战略合作,共创伴随诊断产品市场新概念2021年9月9日,值为真生物13周年之际,与上海桐树基因达成3个伴随诊

  • ABOUT

    Strive for Best, Strive for Greatness

    Weizhenbio Bioengineering Technology Co., Ltd. founded in 2017, is a national-level high-tech enterprise focusing on the construction of immune and molecular POCT production lines. High-end medical device engineering technology research center.

    About us
  • 4200

    Business area

  • 2000million

    Registered capital

  • 33items

    Company patent

  • 60

    R & D personnel

  • Hotline: 0563-2827-888 / 0563-8766-2906

    Address: Building B17, Science and Technology Park, Xuancheng Economic and Technological Development Zone, Anhui Province